Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

The Diagnosis of Tumors by Aspiration.

Stewart FW.

Am J Pathol. 1933;9(Suppl):801-812.3. No abstract available.

2.

BIOPSY BY NEEDLE PUNCTURE AND ASPIRATION.

Martin HE, Ellis EB.

Ann Surg. 1930 Aug;92(2):169-81. No abstract available.

3.

Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma.

Shattuck TM, Westra WH, Ladenson PW, Arnold A.

N Engl J Med. 2005 Jun 9;352(23):2406-12. Erratum in: N Engl J Med. 2005 Oct 13;353(15):1640.

4.

Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness.

Trovisco V, Soares P, Preto A, de Castro IV, Lima J, Castro P, Máximo V, Botelho T, Moreira S, Meireles AM, Magalhães J, Abrosimov A, Cameselle-Teijeiro J, Sobrinho-Simões M.

Virchows Arch. 2005 Jun;446(6):589-95. Epub 2005 May 19.

PMID:
15902486
5.

Prevalence of malignancy within cytologically indeterminate thyroid nodules.

Miller B, Burkey S, Lindberg G, Snyder WH 3rd, Nwariaku FE.

Am J Surg. 2004 Nov;188(5):459-62.

PMID:
15546550
6.

Mutations of the BRAF gene in papillary thyroid carcinoma in a Korean population.

Kim KH, Kang DW, Kim SH, Seong IO, Kang DY.

Yonsei Med J. 2004 Oct 31;45(5):818-21.

7.

Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma.

Salvatore G, Giannini R, Faviana P, Caleo A, Migliaccio I, Fagin JA, Nikiforov YE, Troncone G, Palombini L, Basolo F, Santoro M.

J Clin Endocrinol Metab. 2004 Oct;89(10):5175-80.

PMID:
15472223
8.

Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer.

Xing M, Tufano RP, Tufaro AP, Basaria S, Ewertz M, Rosenbaum E, Byrne PJ, Wang J, Sidransky D, Ladenson PW.

J Clin Endocrinol Metab. 2004 Jun;89(6):2867-72.

PMID:
15181070
9.

Rapid detection of mutations in the BRAF gene using real-time polymerase chain reaction and melting curve analysis.

Ikenoue T, Hikiba Y, Kanai F, Ijichi H, Togo G, Ohta M, Watabe H, Yamaji Y, Okamoto M, Aragaki J, Matsumura M, Kawabe T, Omata M.

Cancer Genet Cytogenet. 2004 Feb;149(1):68-71.

PMID:
15104286
10.

Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid: a potential application for the preoperative assessment of thyroid nodules.

Cohen Y, Rosenbaum E, Clark DP, Zeiger MA, Umbricht CB, Tufano RP, Sidransky D, Westra WH.

Clin Cancer Res. 2004 Apr 15;10(8):2761-5.

11.

BRAF T1796A transversion mutation in various thyroid neoplasms.

Xing M, Vasko V, Tallini G, Larin A, Wu G, Udelsman R, Ringel MD, Ladenson PW, Sidransky D.

J Clin Endocrinol Metab. 2004 Mar;89(3):1365-8.

PMID:
15001635
12.

Cancer statistics, 2004.

Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ; American Cancer Society.

CA Cancer J Clin. 2004 Jan-Feb;54(1):8-29. Review.

13.

BRAF mutations are associated with some histological types of papillary thyroid carcinoma.

Trovisco V, Vieira de Castro I, Soares P, Máximo V, Silva P, Magalhães J, Abrosimov A, Guiu XM, Sobrinho-Simões M.

J Pathol. 2004 Feb;202(2):247-51.

PMID:
14743508
14.

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas.

Nikiforova MN, Kimura ET, Gandhi M, Biddinger PW, Knauf JA, Basolo F, Zhu Z, Giannini R, Salvatore G, Fusco A, Santoro M, Fagin JA, Nikiforov YE.

J Clin Endocrinol Metab. 2003 Nov;88(11):5399-404.

PMID:
14602780
15.

Comparison of completion thyroidectomy and primary surgery for differentiated thyroid carcinoma.

Erdem E, Gülçelik MA, Kuru B, Alagöl H.

Eur J Surg Oncol. 2003 Nov;29(9):747-9.

PMID:
14602494
16.

Beyond the suspicious thyroid fine needle aspirate. A review.

Segev DL, Clark DP, Zeiger MA, Umbricht C.

Acta Cytol. 2003 Sep-Oct;47(5):709-22. Review.

PMID:
14526667
17.

BRAF mutations in papillary carcinomas of the thyroid.

Fukushima T, Suzuki S, Mashiko M, Ohtake T, Endo Y, Takebayashi Y, Sekikawa K, Hagiwara K, Takenoshita S.

Oncogene. 2003 Sep 25;22(41):6455-7.

PMID:
14508525
18.

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers.

Namba H, Nakashima M, Hayashi T, Hayashida N, Maeda S, Rogounovitch TI, Ohtsuru A, Saenko VA, Kanematsu T, Yamashita S.

J Clin Endocrinol Metab. 2003 Sep;88(9):4393-7.

PMID:
12970315
19.

High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.

Xu X, Quiros RM, Gattuso P, Ain KB, Prinz RA.

Cancer Res. 2003 Aug 1;63(15):4561-7.

20.

BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC.

Soares P, Trovisco V, Rocha AS, Lima J, Castro P, Preto A, Máximo V, Botelho T, Seruca R, Sobrinho-Simões M.

Oncogene. 2003 Jul 17;22(29):4578-80.

PMID:
12881714

Supplemental Content

Support Center